- Why Glasgow
- Help & Support
- Media Hub
- Contact Us
Scotland is to have its own £15.8 million artificial intelligence health research centre, which promises to enable better patient diagnosis, treatment and outcomes.
The Industrial Centre for Artificial Intelligence Research in Digital Diagnostics, to be known as iCAIRD, brings together a pan-Scotland collaboration of 15 partners from across academia, the NHS, and industry.
Today (Tuesday 6 November), Greg Clark, UK Secretary of State for Business, Energy and Industrial Strategy (BEIS), will announce that UK Research and Innovation will invest £10million in iCAIRD as part of the Industrial Strategy Challenge Fund.
Partner companies in the University of Glasgow-led pan Scotland consortium, Canon Medical Research Europe Ltd and Philips, along with six SMEs, will provide more than £5 million of additional funding to support iCAIRD.
iCAIRD will be a Scottish centre of excellence and focus on the application of AI in digital diagnostics, ultimately enabling better and earlier diagnosis and more efficient treatment for patients. It is also predicted that iCAIRD will create new jobs centred around AI and digital technology in healthcare.
Centred at the University of Glasgow’s Clinical Innovation Zone at the Queen Elizabeth University Hospital, iCAIRD bring together teams across Scotland – in Aberdeen, St Andrews and Edinburgh – to enable joined-up academic and commercial technology development, alongside academic researchers locally and nationally.
The centre’s work will deliver significant benefits for patients through the development of solutions for more rapid treatment for stroke; expert chest x-ray reading; rapid and more accurate diagnosis in gynaecological disease and colon cancer; and partly automated mammogram analysis for breast cancer screening.
Making use of the capability of modern computers to process the large amounts of data gathered in NHS healthcare clinics, iCAIRD will also allow clinicians, health planners and industry to work together and ultimately solve healthcare challenges more quickly and efficiently, and in a way that completely protects patients’ identities.
Building on significant investment across Scotland, iCAIRD will integrate with Health Data Research UK (HDRUK) and the national Picture Archiving Communication System (PACS) for radiology.
Glasgow – in competition with over 300 cities across the continent – has been ranked as the top large...Read More
Med-tech firm EnMovi has selected the Glasgow City Innovation District as the location to advance the development of cutting-edge...Read More
Glasgow has been voted the World’s Leading Festival and Event Destination 2019 in the 26th annual World Travel Awards,...Read More
Sign-up to our email updates for the latest investment opportunities and information in Glasgow. Fill out the form below with your email.